Simple Urine Test Detects Cancer Before Symptoms Appear

A simple urine test is now catching cancer so early that patients don't even know they're sick yet.

Scientists at Newcastle University have developed a genetic test that spots urinary tract cancers in people with Lynch syndrome before symptoms appear. In a pilot study, the test identified early-stage cancer in five people, four of whom had no idea anything was wrong.

That early catch made all the difference. These patients avoided aggressive treatments and recovered faster because doctors found the cancer when it was still small and manageable.

Professor Sir John Burn, who led the research team, calls the results unprecedented. The test works by identifying specific DNA signatures in urine that are characteristic of Lynch syndrome-related cancers affecting the kidney, bladder, and ureter.

Lynch syndrome is a genetic condition that dramatically increases cancer risk. Around 150,000 people in the UK have it, but over 90% don't know because only 12,000 have been diagnosed.

Without early detection, urinary tract cancer in Lynch syndrome patients often progresses to dangerous stages before treatment begins. This test changes that equation entirely.

The same team previously developed a version of this test for bowel cancer, which is now being rolled out across England. That test not only guides treatment but also identifies Lynch syndrome in patients, allowing their families to get tested and join proactive screening programs.

The Ripple Effect

When one person gets diagnosed with Lynch syndrome through these tests, their entire family benefits. Relatives can receive genetic testing and join monitoring programs that catch multiple types of cancer early, when treatment is most effective.

The test also helps doctors make smarter treatment decisions. It shows whether surgeons successfully removed all the cancer and guides how to target follow-up care precisely.

The Newcastle team is now planning larger studies to validate these promising results. Their goal is establishing a nationwide Lynch syndrome urinary tract cancer surveillance program that could save thousands of lives.

Anyone with a family history of colorectal cancer can ask their doctor for a Lynch syndrome test. Last year, Cancer Research UK recognized the Newcastle team with an award for transforming patient diagnosis.

The research appears in the journal eBioMedicine, marking another step forward in catching cancer before it catches us.